SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
about
SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel Sequencing.The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.
P2860
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@en
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@nl
type
label
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@en
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@nl
prefLabel
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@en
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@nl
P2093
P2860
P50
P1476
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort.
@en
P2093
Alexandra Afenjar
Alexandre Buffet
Alice Goldenberg
Armelle Luscan
Audrey Briand-Suleau
Céline Violle-Poirsier
Dominique Vidaud
Eric Bieth
Geneviève Baujat
Ingrid Laurendeau
P2860
P356
10.1136/JMEDGENET-2015-103638
P407
P577
2016-06-17T00:00:00Z